These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18628607)

  • 1. The prokinetic effect of mosapride citrate on horse gastric emptying rates.
    Okamura K; Sasaki N; Fukunaka M; Yamada H; Inokuma H
    J Vet Med Sci; 2008 Jun; 70(6):627-8. PubMed ID: 18628607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility.
    Okamura K; Sasaki N; Yamada M; Yamada H; Inokuma H
    Res Vet Sci; 2009 Apr; 86(2):302-8. PubMed ID: 18723200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats.
    Uchida M; Yamato S; Shimizu K; Amano T; Ariga H
    J Pharmacol Sci; 2013; 121(4):282-7. PubMed ID: 23514789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mosapride on prednisolone-induced gastric mucosal injury and gastric-emptying disorder in dog.
    Tsukamoto A; Ohno K; Maeda S; Nakashima K; Fukushima K; Fujino Y; Hori M; Tsujimoto H
    J Vet Med Sci; 2012 Sep; 74(9):1103-8. PubMed ID: 22531101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying.
    Asakawa A; Ueno N; Katagi M; Ijuin Y; Morita Y; Mizuno S; Inui T; Sakamaki R; Shinfuku N; Uemoto M
    J Diabetes Complications; 2006; 20(1):56-8. PubMed ID: 16389169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prokinetic effect of the 5-HT4R agonist mosapride on canine gastric motility.
    Tsukamoto A; Ohno K; Maeda S; Nakashima K; Fukushima K; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2011 Dec; 73(12):1635-7. PubMed ID: 21785238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric emptying after artificial ulceration in rats: differences due to the site of the ulcer and the effects of prokinetic drugs.
    Uchida M; Kobayashi O; Shimizu K
    J Smooth Muscle Res; 2017; 53(0):48-56. PubMed ID: 28652516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic evaluation of gastric emptying and effect of mosapride citrate on gastric emptying.
    Jung IS; Kim JH; Lee HY; Park H; Lee SI
    Yonsei Med J; 2010 Jan; 51(1):33-8. PubMed ID: 20046511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of 13C-acetic acid breath test by measuring effects of loperamide, morphine, mosapride, and itopride on gastric emptying in mice.
    Matsumoto K; Kimura H; Tashima K; Uchida M; Horie S
    Biol Pharm Bull; 2008 Oct; 31(10):1917-22. PubMed ID: 18827355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokinetic effect of AS-4370 on gastric emptying in healthy adults.
    Kanaizumi T; Nakano H; Matsui Y; Ishikawa H; Shimizu R; Park S; Kuriya N
    Eur J Clin Pharmacol; 1991; 41(4):335-7. PubMed ID: 1804650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on electrical activity of the small intestine and cecum in horses.
    Sasaki N; Okamura K; Yamada H
    Am J Vet Res; 2005 Aug; 66(8):1321-3. PubMed ID: 16173472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-emetic effect of mosapride citrate hydrate, a 5-HT4 receptor agonist, on selective serotonin reuptake inhibitors (SSRIs)-induced emesis in experimental animals.
    Mine Y; Oku S; Yoshida N
    J Pharmacol Sci; 2013; 121(1):58-66. PubMed ID: 23257657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
    Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
    Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the gastroprokinetic agent mosapride citrate after single oral administration in horses.
    Okamura K; Sasaki N; Fukunaka M; Yamada H; Inokuma H
    J Vet Med Sci; 2010 Aug; 72(8):1023-6. PubMed ID: 20467210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mosapride citrate on gastric motility and autonomic nervous function: evaluation by spectral analyses of heart rate and blood pressure variabilities, and by electrogastrography.
    Endo J; Nomura M; Morishita S; Uemura N; Inoue S; Kishi S; Kawaguchi R; Iga A; Ito S; Nakaya Y
    J Gastroenterol; 2002; 37(11):888-95. PubMed ID: 12483243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.
    Futagami S; Iwakiri K; Shindo T; Kawagoe T; Horie A; Shimpuku M; Tanaka Y; Kawami N; Gudis K; Sakamoto C
    J Gastroenterol; 2010 Apr; 45(4):413-21. PubMed ID: 19997942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.